Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia

被引:0
作者
Maduell, F
Gorriz, JL
Pallardo, LM
Pons, R
Santiago, C
机构
[1] Hosp Gen Castellon, Serv Nefrol, Castellon de La Plana 12004, Spain
[2] Univ Hosp Dr Peset, Dept Nephrol, Valencia, Spain
[3] Alicante Gen Hosp, Dept Nephrol, Alicante, Spain
关键词
bone disease; cardiovascular risk; hemodialysis; K/DOQI guidelines; mineral metabolism;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The objective of the study was to determine the situation concerning mineral metabolism and bone disease in hemodialysis (HD) patients living in the community of Valencia (Spain), as well as the clinical practices for bone disease control in relation to the laboratory targets recommended in the National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) guidelines. Methods: In December 2003, a cross-sectional study was performed including 2392 patients (1485 males and 907 females) from 43 different centers in the council of Valencia (the entire HD population). Mean age was 65.8 +/- 14 yrs. Cut-off levels for the study of calcium, phosphorus, calcium-phosphorus product (Ca x P) and parathyroid hormone (PTH) were performed following the recommendations of the K/DOQI guidelines. Results: The mean values for calcium were 9.57 +/- 0.7 mg/dL, phosphorus 4.97 +/- 1.5 mg/dL, intact PTH (iPTH) 297 353 pg/mL, Ca x P 47.5 +/- 15 mg(2)/dL(2). Hypocalcemia (< 8.4 mg/dL) was present in 5% of patients, whereas 17.8% of patients presented hypercalcemia (> 10.2 mg/dL), 60.3% of whom received vitamin D. Hypophosphoremia (< 3.5 mg/dL) was present in 16% of patients, and 29% of patients presented hyperphosphoremia (> 5.5 mg/dL). Ca x P was < 55 mg(1)/dL(2) in 73% of patients. Thirty one percent of patients presented secondary hyperparathyroidism (HPTH > 300 pg/mL), being severe in 12% (> 600 pg/mL); 43% of patients presented iPTH < 150 pg/mL. Only 7.3% of patients achieved the four recommendations provided in the K/DOQI guidelines. Vitamin D treatment was administered in 48% of patients. Conclusions: The population undergoing dialysis in the community of Valencia achieved targets based on the clinical recommendations of the K/DOQI guidelines as follows: 45% of patients achieved targets for calcium, 55% for phosphorus, 73% for Ca x P and 26% for iPTH levels. Surprisingly, only 7.3% of patients achieved all four targets.
引用
收藏
页码:739 / 748
页数:10
相关论文
共 26 条
  • [21] Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
    Raggi, P
    Boulay, A
    Chasan-Taber, S
    Amin, N
    Dillon, M
    Burke, SK
    Chertow, GM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (04) : 695 - 701
  • [22] Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients:: an open-label, randomized study
    Sadek, T
    Mazouz, H
    Bahloul, H
    Oprisiu, R
    El Esper, N
    El Esper, I
    Boitte, F
    Brazier, M
    Moriniere, P
    Fournier, A
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) : 582 - 589
  • [23] Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes
    Stevens, LA
    Djurdjev, O
    Cardew, S
    Cameron, EC
    Levin, A
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03): : 770 - 779
  • [24] OPTIMUM CALCIUM CONCENTRATION OF DIALYSIS FLUID FOR MAINTENANCE HAEMODIALYSIS
    WING, AJ
    [J]. BRITISH MEDICAL JOURNAL, 1968, 4 (5624) : 145 - &
  • [25] Clinical significance of the K/DOQI bone guidelines in Japan
    Yokoyama, K
    Katoh, N
    Kubo, H
    Murai, S
    Imamura, N
    Shoji, R
    Yamamoto, H
    Shigematsu, T
    Nakayama, M
    Takasu, S
    Kono, T
    Yoshida, T
    Hosoya, T
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) : 383 - 384
  • [26] Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
    Young, EW
    Akiba, T
    Albert, JM
    McCarthy, JT
    Kerr, PG
    Mendelssohn, DC
    Jadoul, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (05) : S34 - S38